Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics

通过新型 OCEAN 技术进行早期检测 - 使用纳米等离子体技术进行卵巢癌外泌体分析

基本信息

  • 批准号:
    10223236
  • 负责人:
  • 金额:
    $ 74.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Extracellular vesicles (EVs) are a new class of circulating biomarker that promises non-invasive, real-time cancer monitoring. Many studies have shown that i) EVs may function as reliable surrogates of parental cancer cells, and ii) these vesicles can reflect global tumor burden, overcoming limitations of tumor heterogeneity and sampling bias. Translating EV analyses into a clinically relevant cancer test, however, is limited by the lack of standardized, practical methods. Conventional assay tools (e.g., ultracentrifugation, Western blotting, ELISA) require large amounts of EVs and extensive processing, making them impractical for clinical workflows. Moreover, variations in sample handling and testing protocols often lead to inconsistent and confounding results. The goal of this proposal is to i) address such technical challenges in EV analyses, and ii) rigorously evaluate EVs' clinical value as a novel biomarker for early detection of ovarian cancer. We formed a strategic academic-industry partnership to achieve this goal: Exosome Diagnostics, an industry leader in EV-based cancer diagnostics, offering ready capacity to develop and manufacture in-vitro diagnostic medical devices; and the Center for Systems Biology at the Massachusetts General Hospital, a pioneer in developing novel analytical technologies for EV analyses. These teams will bring their multidisciplinary expertise, innovative technologies and complementary resources to carry out the following translational projects. First, we will advance a standardized EV assay platform. We will adopt our recently developed ExoLution platform to streamline EV collection, and the nPLEX (nano-plasmonic exosome) technology for high-throughput EV protein screening. Our initial study showed that nPLEX achieved >1000-fold higher sensitivity than conventional methods and yet consumed scant sample volumes (0.1 μL). We now seek to advance nPLEX to the instrument level by i) improving its robustness and throughput, and ii) establishing standardized assay protocols. Leveraging the developmental and regulatory expertise of Exosome Diagnostics, the resulting platform will be ready for translation into clinical diagnostic laboratories. Second, we will perform a targeted clinical study, particularly testing whether EVs can be exploited as a biomarker for early detection of ovarian cancer and progression monitoring. Our preclinical study will use patient-derived ovarian cancer cells and novel genetically engineered mouse models to identify EV protein signatures for ovarian cancer. We will next profile circulating EVs from ovarian cancer patients and assess the correlation between tumor burden and EV protein signature. Our study will be designed to ensure assay reliability and reproducibility, thereby delivering clinically translatable EV diagnostics. We will impose stringent quality controls on device design and sample processing, accrue well-annotated patient and control samples, and perform multisite testing. The technical and scientific outcomes of this research could have a significant translational impact in cancer management, establishing a robust, highly specific liquid biopsy for early detection of ovarian cancer.
细胞外小泡(EVS)是一种新型的非侵入性、实时的循环生物标志物 癌症监测。许多研究表明,EV可以作为父母癌症的可靠替代品 细胞,以及ii)这些囊泡可以反应整体肿瘤负荷,克服肿瘤异质性的限制和 抽样偏差。然而,将EV分析转化为临床相关的癌症测试,受到缺乏 标准化的、实用的方法。常规检测工具(如超速离心法、免疫印迹法、酶联免疫吸附试验) 需要大量的电动汽车和广泛的处理,使它们不切实际的临床工作flOWS。 此外,样品处理和测试方案的变化往往导致不一致和混淆 结果。该提案的目标是i)解决电动汽车分析中的此类技术挑战,以及ii)严格 评价EVS作为卵巢癌早期诊断新生物标志物的临床价值。我们组成了一个战略 实现这一目标的学术-行业合作伙伴关系:基于电动汽车的行业领先者Exosome Diagnostics 癌症诊断,提供开发和制造体外诊断医疗设备的现成能力; 以及马萨诸塞州总医院的系统生物学中心,这是开发新技术的先驱 电动汽车分析的分析技术。这些团队将带来他们的多学科专业知识,创新 技术和补充资源,以开展下列翻译项目。首先,我们将 推进EV标准化检测平台建设。我们将采用我们最近开发的ExoLution平台来 Streamline EV收集,以及用于高通量EV蛋白的NPLEx(纳米等离子外切体)技术 放映。我们的初步研究表明,NPLEx的敏感度是传统的1000倍 方法和消耗的样本量仍然很少(0.1μL)。我们现在寻求将NPLEx提升到该工具 通过i)改进其稳健性和吞吐量,以及ii)建立标准化的检测方案。 利用Exosome诊断公司的开发和监管专业知识,最终的平台将是 准备好转化为临床诊断实验室。第二,我们将进行有针对性的临床研究, 特别是检测EVS是否可以作为卵巢癌早期检测的生物标志物 进度监控。我们的临床前研究将使用患者来源的卵巢癌细胞和新的基因 基因工程小鼠模型,以确定卵巢癌的EV蛋白特征。我们接下来将进行Profile循环 并评估肿瘤负担和EV蛋白信号之间的相关性。 我们的研究将旨在确保分析的可靠性和重复性,从而在临床上提供 可翻译的电动汽车诊断。我们将对设备设计和样品加工实施严格的质量控制, 收集注解良好的患者和对照样本,并进行多点测试。技术和科学fic 这项研究的结果可能会对癌症管理产生重大的翻译影响,建立 一种强大的、高度特异的fic液体活组织检查,用于卵巢癌的早期检测。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cesar M Castro其他文献

Cesar M Castro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cesar M Castro', 18)}}的其他基金

Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array
利用高通量 OCEANA 扩大早期癌症检测 - 使用纳米等离子体阵列进行卵巢癌外泌体分析
  • 批准号:
    10762488
  • 财政年份:
    2023
  • 资助金额:
    $ 74.67万
  • 项目类别:
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach
通过集成 CRISPR 和荧光核酸方法将 CODA 应用于宫颈癌筛查
  • 批准号:
    10647930
  • 财政年份:
    2023
  • 资助金额:
    $ 74.67万
  • 项目类别:
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
膀胱癌免疫疗法的高通量纳米等离子体外泌体测试(NEXT)
  • 批准号:
    10463778
  • 财政年份:
    2021
  • 资助金额:
    $ 74.67万
  • 项目类别:
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
膀胱癌免疫疗法的高通量纳米等离子体外泌体测试(NEXT)
  • 批准号:
    10686016
  • 财政年份:
    2021
  • 资助金额:
    $ 74.67万
  • 项目类别:
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
膀胱癌免疫疗法的高通量纳米等离子体外泌体测试(NEXT)
  • 批准号:
    10305371
  • 财政年份:
    2021
  • 资助金额:
    $ 74.67万
  • 项目类别:
Career Enhancement Program (CEP)
职业提升计划(CEP)
  • 批准号:
    10684244
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
  • 批准号:
    10684196
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
  • 批准号:
    10469368
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
Career Enhancement Program (CEP)
职业提升计划(CEP)
  • 批准号:
    10469379
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics
通过新型 OCEAN 技术进行早期检测 - 使用纳米等离子体技术进行卵巢癌外泌体分析
  • 批准号:
    9982238
  • 财政年份:
    2018
  • 资助金额:
    $ 74.67万
  • 项目类别:

相似海外基金

How novices write code: discovering best practices and how they can be adopted
新手如何编写代码:发现最佳实践以及如何采用它们
  • 批准号:
    2315783
  • 财政年份:
    2023
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Standard Grant
One or Several Mothers: The Adopted Child as Critical and Clinical Subject
一位或多位母亲:收养的孩子作为关键和临床对象
  • 批准号:
    2719534
  • 财政年份:
    2022
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
  • 批准号:
    2633211
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Studentship
A material investigation of the ceramic shards excavated from the Omuro Ninsei kiln site: Production techniques adopted by Nonomura Ninsei.
对大室仁清窑遗址出土的陶瓷碎片进行材质调查:野野村仁清采用的生产技术。
  • 批准号:
    20K01113
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
  • 批准号:
    2436895
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
  • 批准号:
    2633207
  • 财政年份:
    2020
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Studentship
The limits of development: State structural policy, comparing systems adopted in two European mountain regions (1945-1989)
发展的限制:国家结构政策,比较欧洲两个山区采用的制度(1945-1989)
  • 批准号:
    426559561
  • 财政年份:
    2019
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Research Grants
Securing a Sense of Safety for Adopted Children in Middle Childhood
确保被收养儿童的中期安全感
  • 批准号:
    2236701
  • 财政年份:
    2019
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Studentship
A Study on Mutual Funds Adopted for Individual Defined Contribution Pension Plans
个人设定缴存养老金计划采用共同基金的研究
  • 批准号:
    19K01745
  • 财政年份:
    2019
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural and functional analyses of a bacterial protein translocation domain that has adopted diverse pathogenic effector functions within host cells
对宿主细胞内采用多种致病效应功能的细菌蛋白易位结构域进行结构和功能分析
  • 批准号:
    415543446
  • 财政年份:
    2019
  • 资助金额:
    $ 74.67万
  • 项目类别:
    Research Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了